MilliporeSigma Webinars

81. Regulatory Guidance For Bioprocessing Software 2/9/2022

    Gain an understanding of the regulatory requirements for software in a biopharmaceutical GxP environment and how software is invaluable for creating an audit trail, reporting, and automating regulatory-related tasks.

     

82. Process Analytical Technology (PAT) Using Next Generation Raman For Real-Time Bioprocess Monitoring 2/8/2022

    Explore how to implement in-line and real-time monitoring of upstream cell cultures using Raman technology and how it can improve processes, save time, and reduce the risk of contamination and batch failure.

83. Frontiers In Digital Bioprocessing 2/8/2022

    In this talk we will dive into 2 digital technologies: modular design and cloud. Both areas have the potential to accelerate the critical aspects of the facility of the future.

84. Next-Gen Raman PAT For Real-Time Bioprocess Monitoring 2/3/2022

    An introduction to Raman for bioprocess monitoring, an overview of process analytical technology and real-time monitoring benefits, and practical case studies and applications for PAT.

85. Turnkey Solutions For Upstream Cell Culture Processes 1/19/2022

    Learn about the benefits of a one-step and neutral pH feed optimization strategy, the potential application of chemically defined hydrolysates, and supplements targeted at adjusting glycosylation attributes.

86. Application Of Two-Dimensional Chromatography To Improve Productivity Of Analytical Testing Of Cell & Gene Therapy Products 10/13/2021

    Analytical characterization of cell and gene therapy products remains a challenging, costly, and time-consuming task. In this video we present a proof-of-concept work demonstrating application of multidimensional chromatography for characterization of Adenovirus type 5 (Ad5)-based product that not only allowed increased productivity, but also limits the sample volume needed for the analysis.

87. AAV Gene Therapy: Orthogonal Methods To Understand And Define CQAs 10/13/2021

    As with all biopharmaceuticals, it is important to identify and monitor the critical quality attributes (CQAs) of these products to ensure their safety and efficacy. Our experts present a range of orthogonal methods to understand and define the CQAs of AAV products.

88. Getting It Right. A Candid Conversation About Remote Viral Clearance Studies 8/19/2021

    Evolving regulatory guidelines and a global pandemic will not derail your viral clearance study timelines with Provise™ Clearance services.

89. Achieving High Yields In Scalable Xeno-Free Culture Formats With Mesenchymal Stem Cell Medium 7/27/2021

    In this webinar, we will explore the current landscape and future trends of cell culture media for adult mesenchymal stem cells and discuss the options to derive MSC’s from bone marrow in xeno-free conditions from static to microcarrier-based suspension culture platforms. Finally, we will demonstrate the Stemline^® XF MSC Media we’ve developed to reduce scalability roadblocks while maintaining robust performance.

90. Advancing Biopharm Manufacturing And Supply Chain Capabilities With An Integrated eData Solution 4/13/2021

    This webinar describes how the implementation of Pharma 4.0 technologies across the industry offers the promise and opportunity to significantly improve many aspects of Biopharma manufacturing and supply chain capabilities. eData exchange is a critical aspect of realizing the full potential of these digital solutions.